We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 13.04% | 1.30 | 1.20 | 1.40 | 1.30 | 1.15 | 1.15 | 1,153,587 | 13:26:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/2/2018 18:49 | choomi Yes I believe you but please be careful as the MM will trash the stock all the way down to 2p. The only good thing that can come out of it is that 'the patient investor's' 157k holding will be trashed as well. Good luck for you are going to need it. | pwhite73 | |
20/2/2018 15:55 | well I have bought today. Good luck everyone. | choomi | |
20/2/2018 15:53 | And many of us here need counselling | the patient investor | |
20/2/2018 14:49 | Don't get me started on EDL. That company diluted the life out of investors with almost 10billiobs shares in issue | spacedust | |
20/2/2018 14:42 | Would be nice to see another reversal like yesterday and finish the day blue. | spacedust | |
20/2/2018 13:59 | Guys NCCL about to take off. EPC and O&M Bids about to be confirmed..Its looking very much like it will Multi bag instantly then.Just a heads up as NeCondezi is very much under the Radar. | beetroot juice | |
20/2/2018 13:55 | People think we have an agenda to bring the price down and honestly all were trying to do is to tell people to be careful nit because we're nice people because we lost money on this share long time ago, I was lucky to get some money back at 18 pence. But yhe price now is still very high based in the financial numbers. This company is only interested for now is to stay alive as the people who run it are scientists not business people. It might come goid if they last, but as an investor it's far too risky at these prices. There will be a share issue when the price go down | naplion | |
20/2/2018 13:51 | Did u guys notice yesterday when the price recovered. They kept the selling price at 650 even though the buying price went up to 725 they are playing u. | naplion | |
20/2/2018 13:50 | PWhite7320 Feb '18 - 13:48 - 1770 of 1770 (Filtered) Utter weirdo | subiaco | |
20/2/2018 13:48 | There is no nobody selling here. The sales are MM drip shorting the stock to the next placing price. As for news nothing is going to shift the stock upwards permanently except license agreement news. How can they do that without patents.R&D collaborations no natter how much merely keeps them afloat which is what they have been doing for the last 15 years. | pwhite73 | |
20/2/2018 13:40 | FFS, this is a disgrace! | subiaco | |
20/2/2018 13:35 | A lot of people will need almost a 100% rise from here just to break even from the JC fiasco | spacedust | |
20/2/2018 13:34 | Tell me if there was any untruth in My message | spacedust | |
20/2/2018 12:17 | Spoke too soon. Seems like we need fantastic news just to ensure the price doesn't tank too much this year. Fantastic news = little drop in sp No news = moderate drop in sp Bad news = for forbid | spacedust | |
20/2/2018 12:01 | It won't hold up if the sells keep coming. Supply & demand. This needs positive news, more contracts and more awareness in general. | looneytune | |
20/2/2018 12:00 | amazing how it holds any idea why? | the patient investor | |
20/2/2018 11:58 | Sells being soaked up | spacedust | |
20/2/2018 10:57 | "The boys in dark glasses reckon 100p+ is the price that any acquirer would have to pay..." | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions